Home600276 • SHA
Jiangsu Hengrui Pharmaceuticals Co Ltd
Follow
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 8.56B | 12.53% |
Operating expense | 4.88B | 7.13% |
Net income | 2.58B | 24.88% |
Net profit margin | 30.11 | 10.98% |
Earnings per share | — | — |
EBITDA | 2.82B | 22.24% |
Effective tax rate | 13.35% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 36.23B | 55.59% |
Total assets | 62.89B | 30.53% |
Total liabilities | 3.86B | -22.64% |
Total equity | 59.03B | — |
Shares outstanding | 6.47B | — |
Price to book | 7.86 | — |
Return on assets | 11.49% | — |
Return on capital | 12.29% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 2.58B | 24.88% |
Cash from operations | 3.75B | 110.63% |
Cash from investing | -553.06M | 28.47% |
Cash from financing | 8.70B | 7,324.40% |
Net change in cash | 11.91B | 1,228.08% |
Free cash flow | 3.01B | 6.79% |
Previous close
ÂĄ71.09
Day range
ÂĄ69.87 - ÂĄ71.24
Year range
ÂĄ42.24 - ÂĄ74.04
Market cap
447.36B CNY
Avg Volume
78.12M
P/E ratio
60.19
Dividend yield
0.29%
Primary exchange
SHA
About
Jiangsu Hengrui Pharmaceuticals Company Ltd., also known as Jiangsu Hengrui, is a Chinese pharmaceutical company that manufactures and distributes various types of drug packaging materials, cancer-treating antineoplastics, cardiovascular medication, painkillers, antibiotics, and related products. It is the largest listed pharmaceutical company in China. Wikipedia
Founded
Apr 28, 1997
Website
Employees
20,325
